Rasha Al-Lamee
@rallamee
Interventional Cardiology Consultant, Clinical Trialist, Imperial College London. Wife to a rugby obsessed husband and mum to a football obsessed son
ID:916585888574042113
07-10-2017 08:47:59
1,5K Tweets
5,5K Followers
541 Following
I am doing 85 mile Etape Caledonia in 2 weeks raising money for @essex_cf SENZO supporting adults with learning disability in Essex. Raising £5k to refit a shop for adult vocational training. Medlife Crisis (Rohin) Rasha Al-Lamee Tony Young Justin Edinburgh 3 Foundation CellAED
essexcommunityfoundation.enthuse.com/cf/senzo-chari…
No rest for the ORBITA team! Recruitment is going strong for ORBITA-FIRE which is being led by Fiyyaz Ahmed-Jushuf. Thank you to Klio Konstantinou and the Essex CTC a fantastic case this week
@Drkeeble
@dizzledavies73
Q: Does blinding matter in RCTs of surgical procedures? A: Depends on the endpoint JAMA Surgery
We compared placebo-controlled and open-label surgical trials to identify when the placebo effect is most powerful Rasha Al-Lamee Katie Thomas NHLI
jamanetwork.com/journals/jamas…
Hear from Drs Rasha Al-Lamee & Michael Foley who discuss the ORBITA-COSMIC trial results presented at #ACC24 .
The ORBITA-COSMIC trial results show that the #ShockwaveReducer reduced angina frequency and improved heart disease related quality of life. And while the imaging endpoint
Congratulations again to Dr Rasha Al-Lamee, interventional cardiologist Imperial NHS 💙, on your appointment as one of the new deputy editors of JACC Journals ➡️ jacc.org/announcements/…
American College of Cardiology NIHR Imperial BRC NHLI Rasha Al-Lamee
Congratulations to Rasha Al-Lamee and the rest of the team for the latest update from the ORBITA-COSMIC. Another great output for the NIHR Imperial BRC Cardiovascular Theme Imperial NHS 💙 Imperial College London
.Rasha Al-Lamee, interventional cardiology consultant Imperial NHS 💙, said: 'Our study wasn’t able to show how this device works, but it does seem to reduce angina frequency in patients with refractory angina.
'Giving these patients another option for treatment is a positive step.”
Well done to Dr Rasha Al-Lamee, interventional cardiologist Imperial NHS 💙 and senior author of the ORBITA-COSMIC study, and the wider research team on these positive findings 👏🏽
NHLI @Rallamee Ramzi Khamis #Angina
Goodbye #ACC from the ORBITA team. Thank you for featuring our work and see you again next year! Florentina Simader Shayna Chotai Michael Foley Christopher Rajkumar Fiyyaz Ahmed-Jushuf Matthew Shun-Shin
#Jacci made her first air journey home to New England in the care of our Editors and got to meet our fearless leader Harlan Krumholz Mitsuaki Sawano, MD
(1/2) In the aftermath of #ACC24 , it is a good time to review one of the best articles ever written on interpreting clinical trials by Dr. Robert M. Califf :
shorturl.at/qtAK2
Robert Harrington C. Michael Gibson MD Rasha Al-Lamee
Amazing presentation by Michael Foley of ORBITA-COSMIC from Rasha Al-Lamee. Open access pub at thelancet.com/journals/lance….
Coronary sinus reducer reduces symptom burden in patients with refractory angina unsuitable for revascularisation. It appears
to improve endocardial blood flow at stress on #whyCMR .
Brilliant study by Rasha Al-Lamee Michael Foley Matthew Shun-Shin et al
NHLI #ACC2024 The Lancet